2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$472.52+$4.41 (+0.94%)
Price as of Nov 12, 2026 8:20 AM EST- $253.2BMarket Cap
- 43.06%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$472.52+$4.41 (+0.94%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $468.11 | ||
Change | +$2.88 (+0.62%) | ||
Open | $460.98 | ||
High | $468.46 | ||
Low | $459.14 | ||
Previous Close | $465.23 | ||
Volume | 2,006,325 | ||
30-Day Average Volume | 2,760,104 | ||
1-Week Change | -2.17% | ||
1-Month Change | 12.83% | ||
1-Year Change | 43.06% | ||
3-Year Change | 91.59% | ||
5-Year Change | 158.51% | ||
Fundamentals | |||
Shares Outstanding | 540.9M | ||
Total Assets | $96.0B | ||
Market Cap | $253.2B | ||
Enterprise Value | $294.0B | ||
Period: QTR TTM FY | |||
Revenue | $9.9B | ||
Net Income | $3.9B | ||
Free Cash Flow | $3.7B | ||
EBIT | $5.3B | ||
EBITDA | $6.5B | ||
Net Working Capital | $11.1B | ||
EPS | $7.08 | ||
Enterprise Value/EBITDA | 46 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 18 | ||
P/E | 66 | ||
PEG | 1 | ||
Price/Free Cash Flow | 69 | ||
Price/Operating Cash Flow | 60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.15% | ||
Trailing Annual Dividend Yield | 2.12% | ||
Ex-Dividend Date | 11/20/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield